Putnam Investments LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Putnam Investments LLC

$73 Billion
Q4 2023

A detailed history of Putnam Investments LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 1,502,390 shares of DNA stock, worth $11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,502,390

Previous 1,461,569 2.79%

Holding current value

$11 Million

Previous $2.65 Million 4.01%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.26 - $1.79 $51,434 - $73,069	40,821 Added 2.79%	1,502,390 $2.54 Million
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $83,121 - $131,135	51,628 Added 3.66%	1,461,569 $2.65 Million
Q2 2023 Aug 14, 2023	SELL	$1.14 - $1.95 $2.04 Million - $3.49 Million	-1,791,758 Reduced 55.96%	1,409,941 $2.62 Million
Q1 2023 May 22, 2023	BUY	$1.2 - $2.19 $831,747 - $1.52 Million	693,123 Added 27.63%	3,201,699 $4.26 Million
Q4 2022 Feb 14, 2023	BUY	$1.63 - $3.52 $1.23 Million - $2.66 Million	754,733 Added 43.03%	2,508,576 $4.24 Million
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $779,476 - $3.99 Million	1,067,776 Added 155.64%	1,753,843 $5.47 Million
Q2 2022 Aug 15, 2022	BUY	$2.2 - $4.2 $22,193 - $42,369	10,088 Added 1.49%	686,067 $1.63 Million
Q1 2022 May 16, 2022	SELL	$2.83 - $8.69 $318,258 - $977,268	-112,459 Reduced 14.26%	675,979 $2.72 Million
Q4 2021 Feb 14, 2022	SELL	$8.31 - $14.92 $7.13 Million - $12.8 Million	-858,415 Reduced 52.12%	788,438 $6.55 Million
Q3 2021 Nov 15, 2021	BUY	$9.15 - $13.28 $15.1 Million - $21.9 Million	1,646,853 New	1,646,853 $19.1 Million

Others Institutions Holding DNA

# of Institutions

Shares Held

55.6M

Call Options Held

Put Options Held

View Full List

About Ginkgo Bioworks Holdings, Inc.

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.41B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

More about DNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Account

Putnam Investments LLC Ginkgo Bioworks Holdings, Inc. Transaction History